Faculty

PHRM 870, Health Policy

PHRM 826, Introduction to Patient Centered Care

PHRM 841, Professional Program Laboratory

PHRM 845, Integrated Pharmacotherapy III

CLPH 449, Introductory Elective in Psychiatric Pharmacy

CLPH 454, Advanced Elective in Psychiatric Pharmacy

Dr Aziz Outstanding Teacher of the Year Award

PHPR Mentor of the Year Award

PHPR Mortar & Pestle Service Award

National Alliance for Mental Illness (NAMI) President’s Award for Service to Mental Health, Indiana Chapter

Heroes in the Fight Award

Outstanding Faculty Advisor

Preceptor of the Year

Tony and Mary Hulman Human Health Achievement Award, Geriatric Medicine

Wartman C, Walroth TA, Butterfield D, Anderson L, Peters M, Schmelz A, Ott C. Review and evaluation of the role of a psychiatric pharmacist on  medication management in a gender health program. J Am Coll Clin Pharm. 2022;5:1287-93.

Oliver AP, Adams ZW, Ott CA, Agley J. Promoting best practices for managing opioid overdoses in the field: A novel project Extension for Community Healthcare Outcomes program for first responders. Prev Med Rep 2022 Dec;30:1-5.

Gonzalvo JD, Meredith A, Adeoye-Olatunde O, Kimiecik C, Pastakia S, Rodriquez N, Ruiz Y, Ott C et al. A call to action from the Purdue University Center for Health Equity and Innovation. J Am Coll Clin Pharm 2022;5(8):865-74.

Adams ZA, Agley J, Pederson CA, Bell LA, Aalsma MC, Jackson T, Grant MT, Ott CA, Hulvershorn LA. Use of Project ECHO to promote evidence based care for justice involved adults with opioid use disorder. Subst Abus 2022;43(1):336-43.

Titus-Lay EN, Jaynes HA, Muensterman ET, Walroth TA, Ott CA, Desta Z, Williams G et al. Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program. Pharmacotherapy 2021;41(3):238-46.

Yoder R, Hulvershorn L, Ott C, Minshawi-Patterson N. Re: Amantadine for treatment of disruptive mood disregulation disorder symptoms. J Child Adolesc Psychopharmacol 2020;30(8):531-2.

Sinclair JL, Waghmare P, Ott C, Thoma LM. Medical staff perceptions of medication-assisted treatment in a federally qualified health center. J Am Pharm Assoc (2003). 2020;60(3S):S13-S19.e3.

Perry B, Walsh KH, Plawecki MH, Fodstad JC, Blake HS, Hunt A, Ott C et al. Change in psychotropic prescribing patterns among youths in foster care associated with a peer-to-peer physician consultation porgram. J Am Acad Child Adolesc Psychiatry 2019;58(12):1219-22.e1.

Darbishire PL, Devine PS, Proctor AJ, Horner AJ, Hoffman EM, Ott CA et al. National survey exploring drug screening in pharmacy programs. Am J Pharm Educ 2019;83(3):334-41.

McCormick Z, Gilbert JL, Ott CA, Plake KS. Mental health first aid training among pharmacy and other university students and its impact on stigma toward mental illness. Curr Pharm Teach Learn. 2018;10(10):1342-7.

Ott CA. Treatment of anxiety disorders in patients with comorbid bipolar disorder. Ment Health Clin. 2018;8(6):256-63.

Ott CA. Bipolar Disorder. In: 2018-2019 Psychiatric Pharmacotherapy Review Course. College of   Psychiatric and Neurologic Pharmacists. 2017.

Isaacs A, Eaves S, Ott CA. Hyponatremia associated with once-monthly paliperidone use. AnnPharmacotherapy 2017; epub ahead of print, May 2017.

Hanson A, Ott CA, Levin BL. Behavioral Health Services. In: McCarthy (ed), Intro to Health CareDelivery: A Primer for Pharmacists, 6th ed. Jones and Bartlett Publishers, LLC, Sudbury, MA, 2017.

Ott CA. Alzheimer’s disease. In: Schwinghammer TL et al, eds. Pharmacotherapy Casebook: APatient-Focused Approach, 10th ed. New York: McGraw-Hill, 2017.

Ott CA.  Prescription Drug Abuse. In: Murphy JE, Lee MWL, Welty T, eds. Pharmacotherapy Self-Assessment Program, Book 2. Central Nervous System/Pharmacy Practice. Lenexa, KS: AmericanCollege of Clinical Pharmacy, 2015. 125-40.

Ott CA, Ansara ED. Long-Term Care.  In: Allen LV, ed. Remington: The Science and Practice ofPharmacy. 22nd ed. Pharmaceutical Press, London, 2013.

Hoch M, Plake KS, Ott CA, Hudmon KS. Attitudes of individuals with schizophrenia toward Pharmacists. J Am Pharm Assoc 2012;52:783-6.

Rascati K, Richards K, Ott CA, Goddard A, Stafkey-Mailey D, et al. Adherence, persistence of use,and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatr Serv 2011; 62:1032-40.

Wells D, Ott CA. The new marijuana. Ann Pharmacother 2011;45(3):414-17.

Meldrum H, Levin BL, Hanson A, Ott C. Mental Health Services Delivery. In: McCarthy (ed), Intro to Health Care Delivery, 5th ed.  Jones and Bartlett Publishers, LLC. Sudbury, MA, 2011.